Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9575
Gene Symbol: CLOCK
CLOCK
0.060 GeneticVariation phenotype BEFREE Physiology and behaviour are critically dependent on circadian regulation via a core set of clock genes, dysregulation of which leads to metabolic and sleep disturbances. 29982483 2018
Entrez Id: 9575
Gene Symbol: CLOCK
CLOCK
0.060 Biomarker phenotype BEFREE The role of clock genes in ADHD patients with comorbid aggression awaits further research; therefore we also indicate directions for future studies to help increase understanding of the underlying mechanisms in ADHD with comorbid aggression and sleep disturbances. 27836462 2018
Entrez Id: 9575
Gene Symbol: CLOCK
CLOCK
0.060 GeneticVariation phenotype BEFREE The main positive findings refer to associations between selected polymorphisms and: 1) chronotype with the ARNTL gene (rs11824092 and rs1481892) and the CLOCK (rs1268271) 2) sleep duration with the CLOCK gene (rs3805148) and the TIM gene (rs2291739) 3) daytime dysfunction with the PER3 gene (rs228727, rs228642, rs10864315) 4) subjective sleep quality with the ARNTL gene (rs11824092, rs1982350) 5) sleep disturbances with the ARNTL gene (rs11600996) We also found the significant epistatic interactions between polymorphism of the PER3 gene (rs2640909) & the CLOCK gene (rs11932595) and following sleep quality variables: sleep duration, habitual sleep efficiency and subjective sleep quality. 27102916 2016
Entrez Id: 9575
Gene Symbol: CLOCK
CLOCK
0.060 Biomarker phenotype BEFREE Sleep disturbances and circadian CLOCK genes in borderline personality disorder. 22806005 2012
Entrez Id: 9575
Gene Symbol: CLOCK
CLOCK
0.060 GeneticVariation phenotype BEFREE 3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients. 20370469 2010
Entrez Id: 9575
Gene Symbol: CLOCK
CLOCK
0.060 GeneticVariation phenotype BEFREE Sleep disturbances in major depressive disorder (MDD) are characterized by increased sleep latency, poorer sleep efficiency reduced latency to the first rapid eye movement (REM) sleep episode, and early-morning awakening, but there is little data to indicate a role of circadian clock genes in MDD. 17969870 2007
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.050 Biomarker phenotype BEFREE This review describes how neurotoxic and genetic manipulations of rats and mice have been utilized to reproduce some of the major sleep disturbances associated with PD and to what extent these abnormalities can be linked to nondopaminergic dysfunction, affecting for instance noradrenaline, serotonin, and orexin transmission. 31827439 2019
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.050 Biomarker phenotype BEFREE Orexin receptor antagonists may have therapeutic value in the treatment of insomnia, yet the use of this class of drugs in the treatment of sleep disturbances following adolescent alcohol exposure has not been studied. 31659377 2019
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.050 AlteredExpression phenotype BEFREE We found that the age at which orexin activity starts to deviate from normal activity pattern coincides with that of sleep disturbances as well as the beta activity. 30915710 2019
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.050 AlteredExpression phenotype BEFREE Hyper-activation of the orexin system also causes sleep disturbances, such as insomnia, and hence, suvorexant, an orexin receptor antagonist, has been clinically used to treat insomnia. 29289556 2018
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.050 Biomarker phenotype BEFREE Disruption of orexin signaling leads to sleep disturbances and increased body mass index, but recent studies also indicate that orexin neuron activation improves learning and memory. 29107703 2017
Entrez Id: 348
Gene Symbol: APOE
APOE
0.040 Biomarker phenotype BEFREE There is no evidence that APOE ε4 carriership or zygosity is associated with the presence of depression, anxiety, apathy, agitation, irritability or sleep disturbances in cognitively impaired subjects. 30513312 2019
Entrez Id: 348
Gene Symbol: APOE
APOE
0.040 Biomarker phenotype BEFREE There was a sleep-APOE ε4 interaction (P = .001) in which patients with the APOE ε4 allele and sleep disturbances had significantly lower learning and memory scores than those who were APOE ε4-negative and without sleep disturbances. 31553501 2019
Entrez Id: 348
Gene Symbol: APOE
APOE
0.040 GeneticVariation phenotype BEFREE This investigation found a significant relationship between presence of APOE ε4 allele and objective sleep disturbances measured by both actigraphy and PSG, but not subjective sleep complaints in a healthy population screened for dementia. 27777343 2016
Entrez Id: 348
Gene Symbol: APOE
APOE
0.040 GeneticVariation phenotype BEFREE Genetic association between APOE-ϵ4 genotype and sleep disturbances was assessed using unadjusted linear regression models. 26314507 2015
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.030 Biomarker phenotype BEFREE <b>Conclusion:</b> Elevated IL-6 levels were observed in MDD patients and IL-6 may correlate with sleep disturbances. 31417262 2019
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.030 GeneticVariation phenotype BEFREE The role of serotonin transporter and its functional gene polymorphism (5-HTTLPR, serotonin transporter linked polymorphic region) was investigated in sleep disturbances in various mental disorders, with conflicting findings. 30948693 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.030 Biomarker phenotype BEFREE The adjusted RRs for these symptoms at age 18 years for participants in top, compared with bottom, third of IL-6 at age 9 years were 1.75 (95% CI, 1.13-2.69) for diurnal mood variation, 1.50 (95% CI, 1.11-2.02) for concentration difficulties, 1.31 (95% CI, 1.12-1.54) for fatigue, and 1.24 (95% CI, 1.01-1.52) for sleep disturbances. 30414442 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.030 Biomarker phenotype BEFREE This study examined Interleukin-6 (IL-6) relations with BMI, tobacco use history, and sleep disturbances in patients undergoing surgery for suspected gynecologic cancer. 31368718 2019
Entrez Id: 8863
Gene Symbol: PER3
PER3
0.030 Biomarker phenotype BEFREE Due to the role of PER3 in sleep disturbances and regulation of immune response, it is possible that PER3 dysregulation increase risk of MS disease. 29055480 2017
Entrez Id: 8863
Gene Symbol: PER3
PER3
0.030 GeneticVariation phenotype BEFREE The main positive findings refer to associations between selected polymorphisms and: 1) chronotype with the ARNTL gene (rs11824092 and rs1481892) and the CLOCK (rs1268271) 2) sleep duration with the CLOCK gene (rs3805148) and the TIM gene (rs2291739) 3) daytime dysfunction with the PER3 gene (rs228727, rs228642, rs10864315) 4) subjective sleep quality with the ARNTL gene (rs11824092, rs1982350) 5) sleep disturbances with the ARNTL gene (rs11600996) We also found the significant epistatic interactions between polymorphism of the PER3 gene (rs2640909) & the CLOCK gene (rs11932595) and following sleep quality variables: sleep duration, habitual sleep efficiency and subjective sleep quality. 27102916 2016
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.030 GeneticVariation phenotype BEFREE Instead, based on current and previous findings, it is suggested that the S'/S' 5-HTTLPR genotype promotes the risk for stress-related sleep disturbances because of an increased susceptibility to the depressogenic consequences of stress. 25644221 2015
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.030 GeneticVariation phenotype BEFREE Direct associations were identified between the dopamine receptor 3 (DRD3) BalI polymorphism and depression; the dopamine receptor 1 (DRD1) and dopamine transporter gene 3' VNTR polymorphisms and aberrant motor behavior; the DRD4 VNTR and sleep disturbances; and the SERT gene VNTR 5HTTLPR and apathy items. 20685009 2012
Entrez Id: 8863
Gene Symbol: PER3
PER3
0.030 GeneticVariation phenotype BEFREE One balanced translocation carrier parent had disruption of the period homolog 3 (PER3) gene and reported sleep disturbances. 18958851 2008
Entrez Id: 4036
Gene Symbol: LRP2
LRP2
0.020 Biomarker phenotype BEFREE The whole group (n = 36) was assessed using motor, non-motor symptoms (sleep disturbances in particular) and quality of life measures (QoL), before surgery, 6 and 12 months after DBS programming. 30975618 2019